Nitazoxanide, a broad-spectrum antiparasitic, has been proposed as a possible COVID-19 therapeutic.
In vitro anti-SARS-CoV-2 activity
Nitazoxanide shows anti-SARS-CoV-2 activity in Vero E6 cells.
Nitazoxanide, a broad-spectrum antiparasitic, has been proposed as a possible COVID-19 therapeutic.
Nitazoxanide shows anti-SARS-CoV-2 activity in Vero E6 cells.